About Marie Guillou

This author has not yet filled in any details.
So far Marie Guillou has created 392 blog entries.

QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study

2024-10-01T10:49:47+02:00

Publication - Epub 2020 Sep 16. QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study [...]

QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study2024-10-01T10:49:47+02:00

Initial validation of the epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire

2024-10-01T10:50:35+02:00

Publication - Epub 2020 Sep 7. Initial validation of the epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire [...]

Initial validation of the epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire2024-10-01T10:50:35+02:00

Development of an international core domain set for medium, large and giant congenital melanocytic naevi as a first step towards a core outcome set for clinical practice and research

2024-10-16T11:15:33+02:00

Publication - Epub 2020 Nov 25. Development of an international core domain set for medium, large and giant congenital melanocytic naevi as a first step [...]

Development of an international core domain set for medium, large and giant congenital melanocytic naevi as a first step towards a core outcome set for clinical practice and research2024-10-16T11:15:33+02:00

Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology

2024-10-01T10:17:24+02:00

Publication - Nov 2020. Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology Authors Ninavan Beek, [...]

Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology2024-10-01T10:17:24+02:00

Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility

2024-10-01T10:51:56+02:00

Publication - Epub 2020 Mar 11. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility Authors C Has, [...]

Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility2024-10-01T10:51:56+02:00

Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-Consensus: Recommendations by an international panel of experts

2024-10-01T10:52:53+02:00

Publication - Epub 2020 Jul 16. Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-Consensus: Recommendations by an international panel of experts [...]

Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-Consensus: Recommendations by an international panel of experts2024-10-01T10:52:53+02:00

Coordinating Center

  • Hôpital Necker Enfants Malades
  • Department of Dermatology
  • 149 rue de Sèvres
  • 75015 Paris

ERN-Skin is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States.
The ERNs are funded by the European Commission.
For more information about the ERNs and the EU health strategy, please visit https://ec.europa.eu/health/ern

© Copyright 2012 -    |   ERN Skin  |   All Rights Reserved